Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cadoo, Karen
134  Ergebnisse:
Personensuche X
?
1

Modifiable risk factors for cancer among people with lynch ..:

Power, Robert F. ; Doherty, Damien E. ; Horgan, Roberta...
Hereditary Cancer in Clinical Practice.  22 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Pathogenic germline variants in patients with endometrial c..:

Liu, Ying L. ; Gordhandas, Sushmita ; Arora, Kanika...
Cancer.  130 (2023)  4 - p. 576-587 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Comprehensive analysis of germline drivers in endometrial c..:

Gordhandas, Sushmita ; Rios-Doria, Eric ; Cadoo, Karen A...
JNCI: Journal of the National Cancer Institute.  115 (2023)  5 - p. 560-569 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Durvalumab with or without tremelimumab in patients with pe..:

Rubinstein, Maria M. ; Doria, Eric Rios ; Konner, Jason...
Gynecologic Oncology.  169 (2023)  - p. 64-69 , 2023
Link: https://doi.org/10.1016/..
 
?
5

When is the Best Time to Use PARP Inhibitors for Maintenanc..:

, In: 50 Big Debates in Gynecologic Oncology,
Al-Rawi, Duaa H. ; Cadoo, Karen ; O'Cearbhaill, Roisin - p. 95-97 , 2023
Link: https://doi.org/10.1017/..
 
?
6

Molecular Profiling Should be Done to Guide the Management ..:

, In: 50 Big Debates in Gynecologic Oncology,
Cadoo, Karen - p. 179-181 , 2023
Link: https://doi.org/10.1017/..
 
?
7

Evaluating the role of aromatase inhibitors in the treatmen..:

Crowley, Fionnuala ; Cadoo, Karen A. ; Chiang, Sarah...
Gynecologic Oncology Reports.  40 (2022)  - p. 100980 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Gastric-type adenocarcinoma of the cervix: Clinical outcome..:

Ehmann, Sarah ; Sassine, Dib ; Straubhar, Alli M....
Gynecologic Oncology.  167 (2022)  3 - p. 458-466 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Early age of onset and broad cancer spectrum persist in MSH..:

Liu, Ying L. ; Cadoo, Karen A. ; Maio, Anna...
Genetics in Medicine.  24 (2022)  6 - p. 1187-1195 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Olaparib treatment for platinum-sensitive relapsed ovarian ..:

Cadoo, Karen ; Simpkins, Fiona ; Mathews, Cara...
Gynecologic Oncology.  166 (2022)  3 - p. 425-431 , 2022
Link: https://doi.org/10.1016/..
 
?
11

PARP Inhibitors in Advanced Prostate Cancer in Tumors with ..:

McNevin, Ciara S. ; Cadoo, Karen ; Baird, Anne-Marie..
Cancers.  14 (2022)  19 - p. 4751 , 2022
Link: https://doi.org/10.3390/..
 
?
12

Inherited Germline Cancer Susceptibility Gene Variants in I..:

Pietzak, Eugene J. ; Whiting, Karissa ; Srinivasan, Preethi...
Clinical Cancer Research.  28 (2022)  19 - p. 4267-4277 , 2022
Link: https://doi.org/10.1158/..
 
?
13

A phase I open-label study of selinexor with paclitaxel and..:

Rubinstein, Maria M. ; Grisham, Rachel N. ; Cadoo, Karen...
Gynecologic Oncology.  160 (2021)  1 - p. 71-76 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Olaparib treatment in patients with platinum-sensitive rela..:

Cadoo, Karen ; Simpkins, Fiona ; Mathews, Cara...
Gynecologic Oncology.  162 (2021)  - p. S217 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Uptake and acceptability of a mainstreaming model of heredi..:

Hamilton, Jada G. ; Symecko, Heather ; Spielman, Kelsey...
Genetics in Medicine.  23 (2021)  11 - p. 2105-2113 , 2021
Link: https://doi.org/10.1038/..
 
1-15